Literature DB >> 27556909

ACUTE MACULAR NEURORETINOPATHY AFTER RANIBIZUMAB INJECTION IN A DIABETIC PATIENT.

H Matthew Wheatley1, David Sarraf.   

Abstract

PURPOSE: To report a case of acute macular neuroretinopathy occurring after intravitreal ranibizumab injection for diabetic macular edema.
METHODS: Observational clinical case report.
RESULTS: The patient received an intravitreal ranibizumab (0.3 mg) injection for diabetic macular edema. Three days later, he had a decline in vision associated with a central and paracentral scotoma. Optical coherence tomography (OCT) demonstrated bandlike hyperreflectivity of the outer nuclear and plexiform layers corresponding to the patient's scotoma, consistent with the diagnosis of acute macular neuroretinopathy. There was spontaneous resolution of the abnormalities observed in optical coherence tomography, but only partial resolution of the scotoma was observed 4 months after presentation.
CONCLUSION: Diabetic retinopathy may be associated with acute macular neuroretinopathy. The temporal relationship between ranibizumab injection and the onset of acute macular neuroretinopathy in this case report raises the possibility of a causal relationship.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27556909     DOI: 10.1097/ICB.0000000000000386

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  1 in total

1.  Acute macular neuroretinopathy associated with intravitreal anti-VEGF injection: A case report.

Authors:  Loubna M Radwan; Ghazi O Bou Ghanem; Ghassan N Daye; Nicola G Ghazi
Journal:  Am J Ophthalmol Case Rep       Date:  2022-08-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.